A new trading day began on Monday, with Phathom Pharmaceuticals Inc (NASDAQ: PHAT) stock price down -3.48% from the previous day of trading, before settling in for the closing price of $16.08. PHAT’s price has ranged from $6.07 to $19.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -42.84%. With a float of $37.51 million, this company’s outstanding shares have now reached $57.97 million.
In an organization with 452 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.86%, operating margin of -2548.78%, and the pretax margin is -2995.67%.
Phathom Pharmaceuticals Inc (PHAT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Phathom Pharmaceuticals Inc is 45.07%, while institutional ownership is 47.58%. The most recent insider transaction that took place on Jul 15 ’24, was worth 127,760. In this transaction Chief Operating Officer of this company sold 10,901 shares at a rate of $11.72, taking the stock ownership to the 240,421 shares. Before that another transaction happened on Jul 15 ’24, when Company’s CFO and CBO sold 4,325 for $11.72, making the entire transaction worth $50,689. This insider now owns 99,447 shares in total.
Phathom Pharmaceuticals Inc (PHAT) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.76 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -42.84% per share during the next fiscal year.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Here are Phathom Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.44. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 106.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.13, a number that is poised to hit -1.47 in the next quarter and is forecasted to reach -4.43 in one year’s time.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.84 million. That was better than the volume of 0.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 50.13%. Additionally, its Average True Range was 1.11.
During the past 100 days, Phathom Pharmaceuticals Inc’s (PHAT) raw stochastic average was set at 60.02%, which indicates a significant increase from 25.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.32% in the past 14 days, which was lower than the 64.69% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.21, while its 200-day Moving Average is $11.39. However, in the short run, Phathom Pharmaceuticals Inc’s stock first resistance to watch stands at $16.05. Second resistance stands at $16.59. The third major resistance level sits at $16.90. If the price goes on to break the first support level at $15.20, it is likely to go to the next support level at $14.89. The third support level lies at $14.35 if the price breaches the second support level.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Key Stats
With a market capitalization of 1.06 billion, the company has a total of 58,535K Shares Outstanding. Currently, annual sales are 680 K while annual income is -201,590 K. The company’s previous quarter sales were 7,320 K while its latest quarter income was -91,450 K.
